A narrative review of vascular conduits for coronary artery bypass grafting
Coronary artery bypass grafting (CABG) involves creating new conduits to restore blood flow to the heart. Using autologous vascular grafts presents challenges, including infection risk after vein harvesting, and scarcity of viable vein tissue. Researchers are exploring tissue-engineered vascular gra...
| Autores: | , , , , , , |
|---|---|
| Formato: | artículo |
| Fecha de publicación: | 2025 |
| País: | España |
| Recursos: | Universitat Autònoma de Barcelona |
| Repositorio: | Dipòsit Digital de Documents de la UAB |
| Idioma: | inglés |
| OAI Identifier: | oai:dnet:uabarcelona_::fc645114f07d4a759313d58b29eb9d23 |
| Acesso em linha: | https://ddd.uab.cat/record/326402 https://dx.doi.org/urn:doi:10.1177/09636897251407160 |
| Access Level: | acceso abierto |
| Palavra-chave: | Coronary artery disease Coronary artery bypass grafting Tissue-engineered vascular grafts Cell seeding Stem cells Small-diameter conduits clinical translation of TEVG |
| Resumo: | Coronary artery bypass grafting (CABG) involves creating new conduits to restore blood flow to the heart. Using autologous vascular grafts presents challenges, including infection risk after vein harvesting, and scarcity of viable vein tissue. Researchers are exploring tissue-engineered vascular grafts (TEVGs), aiming to create optimal small-diameter vascular graft (SDVG). |
|---|